|
2008 Journal Article Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53 and p16 immunostaining in cutaneous melanomasRichmond-Sinclair, N.M., Lee, E., Cummings, M.C., Williamson, R., Muller, H.K., Green, A.C., Hayward, N.K. and Whiteman, D.C. (2008). Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53 and p16 immunostaining in cutaneous melanomas. Melanoma research, 18 (5), 336-345. doi: 10.1097/CMR.0b013e32830d8329 |
|
2007 Journal Article Genome-wide association study identifies novel breast cancer susceptibility lociEaston, Douglas F., Pooley, Karen A., Dunning, Alison M., Pharoah, Paul D. P., Thompson, Deborah, Ballinger, Dennis G., Struewing, Jeffery P., Morrison, Jonathan, Field, Helen, Luben, Robert, Wareham, Nicholas, Ahmed, Shahana, Healey, Catherine S., Bowman, Richard, SEARCH collaborators, Meyer, Kerstin B., Haiman, Christopher A., Kolonel, Laurence K., Henderson, Brian E., Marchand, Loic Le, Brennan, Paul, Sangrajrang, Suleeporn, Gaborieau, Valerie, Odefrey, Fabrice, Shen, Chen-Yang, Wu, Pei-Ei, Wang, Hui-Chun, Eccles Diana, Evans, D. Gareth ... Ward, Robyn (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447 (7148), 1087-1093. doi: 10.1038/nature05887 |
|
2006 Journal Article Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survivalHerath, Nirmitha I., Spanevello, Mark D., Sabesan, Sabe, Newton, Tanya, Cummings, Margaret, Duffy, Shannon, Lincoln, Douglas, Boyle, Glen, Parsons, Peter G. and Boyd, Andrew W. (2006). Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. BMC Cancer, 6 (144) 144, 144. doi: 10.1186/1471-2407-6-144 |
|
2006 Journal Article Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variance of Unknown Clinical SignificanceChenevix-Trench, Georgia, Healey, Sue, Lakhani, Sunil, Waring, Paul, Cummings, Margaret, Brinkworth, Ross, Deffenbaugh, Amie M., Burbidge, Lynn Anne, Pruss, Dmitry, Judkins, Thad, Scholl, Tom, Bekessy, Anna, Marsh, Anna, Lovelock, Paul, Wong, Ming, Tesoriero, Andrea, Renard, Helene, Southey, Melissa, Hopper, John L., Yannoukakos, Koulis, Brown, Melissa, kConFab Investigators, Easton, Douglas, Tavtigian, Sean V., Goldgar, David and Spurdle, Amanda B. (2006). Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variance of Unknown Clinical Significance. Cancer Research, 66 (4), 2019-2027. doi: 10.1158/0008-5472.CAN-05-3546 |
|
2006 Journal Article Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testingFarshid, G, Balleine, RL, Cummings, M, Waring, P and kConFab Grp (2006). Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing. American Journal of Surgical Pathology, 30 (11), 1357-1366. doi: 10.1097/01.pas.0000213273.22844.1a |
|
2006 Journal Article Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistryBilous, Michael, Morey, Adrienne, Armes, Jane, Cummings, Margaret and Francis, Glenn (2006). Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry. Pathology, 38 (2), 120-124. doi: 10.1080/00313020600561518 |
|
2006 Journal Article Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancerNewton, Tanya R., Parsons, Peter G., Lincoln, Douglas J., Cummings, Margaret C., Wyld, David K., Webb, Penelope M., Green, Adele C. and Boyle, Glen M. (2006). Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer. International Journal of Cancer, 119 (4), 875-883. doi: 10.1002/ijc.21823 |
|
2005 Journal Article Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinomaArnold, J. M., Huggard, P. R., Cummings, M., Ramm, G. A. and Chenevix-Trench, G. (2005). Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma. British Journal of Cancer, 92 (11), 2024-2031. doi: 10.1038/sj.bjc.6602596 |
|
2004 Journal Article Changes in survival after breast cancer: improvements in diagnosis or treatment?Webb, PM, Cummings, MC, Bain, CJ and Furnival, CM (2004). Changes in survival after breast cancer: improvements in diagnosis or treatment?. Breast, 13 (1), 7-14. doi: 10.1016/S0960-9776(03)00129-2 |
|
2003 Journal Article Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability statusMichael-Robinson, Julie M., Pandeya, Nirmala, Cummings, Margaret C., Walsh, Michael D., Young, Joanne P., Leggett, Barbara A., Purdie, David M., Jass, Jeremy R. and Radford-Smith, Graham L. (2003). Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status. Journal of Pathology, 201 (1), 46-54. doi: 10.1002/path.1406 |
|
2003 Journal Article Occult metastases in breast cancerCummings, M. C. (2003). Occult metastases in breast cancer. Cancer Forum, 27 (2), 95-97. |
|
2003 Journal Article Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International StudyBilous, M., Ades, C., Armes, J., Bishop, J., Brown, R., Cooke, B., Cummings, M., Farshid, G., Field, A., Morey, A., McKenzie, P., Raymond, W., Robbins, P. and Tan, L. (2003). Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study. Breast, 12 (2), 92-98. doi: 10.1016/S0960-9776(02)00273-4 |
|
2002 Journal Article Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysisCummings, M. C., Walsh, M. D., Hohn, B. G, Bennett, I. C., Wright, R. G. and McGuckin, M. A. (2002). Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis. American Journal of Surgical Pathology, 26 (10), 1286-1295. doi: 10.1097/00000478-200210000-00005 |
|
2002 Journal Article Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanomaWhiteman, David C., Zhou, Xiao-Ping, Cummings, Margaret C., Pavey, Sandra, Hayward, Nicholas K. and Eng, Charis (2002). Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma. International Journal of Cancer, 99 (1), 63-67. doi: 10.1002/ijc.10294 |
|
2002 Journal Article Dominant negative ATM mutations in breast cancer familiesChenevix-Trench, Georgia, Spurdle, Amanda B., Gatei, Magtouf, Kelly, Helena, Marsh, Anna, Chen, Xiaoqing, Donn, Karen, Cummings, Margaret C., Nyholt, Dale, Jenkins, Mark A., Scott, Clare, Pupo, Gulietta M., Dork, Thilo, Bendix, Regina, Kirk, Judy, Tucker, Katherine, McCredie, Margaret R. E., Hopper, John L., Sambrook, Joseph, Mann, Graham J. and Khanna, Kum Kum (2002). Dominant negative ATM mutations in breast cancer families. Journal of the National Cancer Institute, 94 (3), 205-215. doi: 10.1093/jnci/94.3.205 |
|
2002 Journal Article Loss of p16 expression is associated with histological features of melanoma invasionPavey, S. J., Cummings, M. C., Whiteman, D. C., Castellano, M., Walsh, M. D., Gabrielli, B. G., Green, A. and Hayward, N. K. (2002). Loss of p16 expression is associated with histological features of melanoma invasion. Melanoma Research, 12 (6), 539-547. doi: 10.1097/01.cmr.0000043154.28051.9f |
|
2001 Journal Article HER2 testing recommendations in AustraliaBilous, Michael, Ades, Colin, Armes, Jane, Bell, Richard, Brown, Robert, Cook, Bridget, Cummings, Margaret C., Field, Andrew, Llewellyn, Huw, McKenzie, Paul, Raymond, Wendy, Robbins, Peter and Tan, Lisa (2001). HER2 testing recommendations in Australia. Pathology, 33 (4), 425-427. doi: 10.1080/00313020120083133 |
|
2001 Journal Article Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomasArnold, J. M., Cummings, M., Purdie, D. and Chenevix-Trench, G. (2001). Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. British Journal of Cancer, 85 (9), 1351-1358. doi: 10.1054/bjoc.2001.2075 |
|
2000 Journal Article Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemiaBellomo, D., Headrick, J. P., Silins, G. U., Paterson, C. A., Thomas, P. S., Gartside, M., Mould, A., Cahill, M. M., Tonks, I. D., Grimmond, S. M., Wells, C. A., Little, M. H., Cummings, M. C., Hayward, N. K. and Kay, G. F. (2000). Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circulation Research, 86 (2), E29-E35. |
|
2000 Journal Article Expression of p53 in arsenic-related and sporadic basal cell carcinomaBoonchai, Waranya, Walsh, Michael, Cummings, Margaret and Chenevix-Trench, Georgia (2000). Expression of p53 in arsenic-related and sporadic basal cell carcinoma. Archives of Dermatology, 136 (2), 195-198. doi: 10.1001/archderm.136.2.195 |
